Wyeth faces trial over generic Effexor delay

Bird & Bird 2018-06-01 11:21 pm By Miklos Bolza | Sydney

Please login to bookmark

A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au